247 related articles for article (PubMed ID: 37627216)
1. Decoding the Complexity of Immune-Cancer Cell Interactions: Empowering the Future of Cancer Immunotherapy.
Maffuid K; Cao Y
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627216
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell Informatics for Tumor Microenvironment and Immunotherapy.
Tian J; Bai X; Quek C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674070
[TBL] [Abstract][Full Text] [Related]
3. Utilizing a Proximity Dependent Labeling Strategy to Study Cancer-Immune Intercellular Interactions In Vitro and In Vivo.
Maffuid K; Cao Y
J Pharmacol Exp Ther; 2024 May; 389(3):246-253. PubMed ID: 37770200
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming the tumor microenvironment by genome editing for precision cancer therapy.
Liu K; Cui JJ; Zhan Y; Ouyang QY; Lu QS; Yang DH; Li XP; Yin JY
Mol Cancer; 2022 Apr; 21(1):98. PubMed ID: 35410257
[TBL] [Abstract][Full Text] [Related]
5. Single-cell N
Gao Y; Wang H; Chen S; An R; Chu Y; Li G; Wang Y; Xie X; Zhang J
J Transl Med; 2022 May; 20(1):197. PubMed ID: 35509079
[TBL] [Abstract][Full Text] [Related]
6. Intravital imaging of the functions of immune cells in the tumor microenvironment during immunotherapy.
Peng X; Wang Y; Zhang J; Zhang Z; Qi S
Front Immunol; 2023; 14():1288273. PubMed ID: 38124754
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.
Apollonio B; Ioannou N; Papazoglou D; Ramsay AG
Front Oncol; 2021; 11():626818. PubMed ID: 33842331
[TBL] [Abstract][Full Text] [Related]
9. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
10. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract][Full Text] [Related]
11. Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue.
Arima Y; Matsueda S; Saya H
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174001
[TBL] [Abstract][Full Text] [Related]
12. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
Balta E; Wabnitz GH; Samstag Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
[TBL] [Abstract][Full Text] [Related]
14. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle mediated cancer immunotherapy.
Gupta J; Safdari HA; Hoque M
Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
[TBL] [Abstract][Full Text] [Related]
16. Exosomes-mediated crosstalk between glioma and immune cells in the tumor microenvironment.
Guo X; Sui R; Piao H
CNS Neurosci Ther; 2023 Aug; 29(8):2074-2085. PubMed ID: 37170647
[TBL] [Abstract][Full Text] [Related]
17. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression.
Saleh R; Elkord E
Semin Cancer Biol; 2020 Oct; 65():13-27. PubMed ID: 31362073
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.
Li A; Ji B; Yang Y; Ye B; Zhu Q; Hu X; Liu Y; Zhou P; Liu J; Gao R; Zhou Q; Kang B; Jiang Y
Front Immunol; 2023; 14():1164448. PubMed ID: 37383234
[TBL] [Abstract][Full Text] [Related]
19. Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects.
Peters S; Paz-Ares L; Herbst RS; Reck M
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35858709
[TBL] [Abstract][Full Text] [Related]
20. Understanding the tumor microenvironment for effective immunotherapy.
Sadeghi Rad H; Monkman J; Warkiani ME; Ladwa R; O'Byrne K; Rezaei N; Kulasinghe A
Med Res Rev; 2021 May; 41(3):1474-1498. PubMed ID: 33277742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]